Jonsson Comprehensive Cancer Center
🇺🇸United States
Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
- First Posted Date
- 2009-11-01
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT01005472
- Locations
- 🇺🇸
University of California Los Angeles (UCLA), Los Angeles, California, United States
Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
Not Applicable
Withdrawn
- Conditions
- Breast CancerAlopecia
- Interventions
- Drug: placebo
- First Posted Date
- 2009-10-22
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00999557
- Locations
- 🇺🇸
University of California Los Angeles, Los Angeles, California, United States
Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Phase 2
Completed
- Conditions
- Brain and Central Nervous System Tumors
- Interventions
- First Posted Date
- 2009-10-20
- Last Posted Date
- 2020-08-28
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT00998010
- Locations
- 🇺🇸
University of California Los Angeles, Los Angeles, California, United States
Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men
Not Applicable
Completed
- Conditions
- Anal CancerNonneoplastic ConditionPrecancerous Condition
- Interventions
- Other: Papanicolaou test
- First Posted Date
- 2009-08-10
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 48
- Registration Number
- NCT00955591
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
Active Surveillance for Cancer of the Prostate (ASCaP)
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Other: Active surveillance
- First Posted Date
- 2009-07-30
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 462
- Registration Number
- NCT00949819
- Locations
- 🇺🇸
University of California Los Angeles, Los Angeles, California, United States
Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
Phase 2
Completed
- Conditions
- Metastatic Melanoma
- Interventions
- Biological: F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cellsDrug: non-myeloablative conditioning chemotherapy
- First Posted Date
- 2009-06-01
- Last Posted Date
- 2021-12-06
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 14
- Registration Number
- NCT00910650
- Locations
- 🇺🇸
University of California Los Angeles, David Geffen School of Medicine, Los Angeles, California, United States
Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Phase 2
Withdrawn
- Conditions
- Pancreatic Cancer
- Interventions
- Dietary Supplement: genistein
- First Posted Date
- 2009-04-16
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00882765
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery
- First Posted Date
- 2009-04-13
- Last Posted Date
- 2020-08-10
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT00880542
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Low-Fat Fish Oil Diet for Prostate Cancer Prevention
Not Applicable
Completed
- Conditions
- Prostate Cancer
- Interventions
- Dietary Supplement: Western DietDietary Supplement: Fish OilOther: Medical ExaminationDietary Supplement: Vitamin E supplementDietary Supplement: Low-Fat DietOther: Dietary InterviewOther: Blood DrawProcedure: Radical Prostatectomy
- First Posted Date
- 2008-11-26
- Last Posted Date
- 2019-05-07
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 56
- Registration Number
- NCT00798876
- Locations
- 🇺🇸
West Los Angeles VA, Los Angeles, California, United States
🇺🇸UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2012-07-31
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT00790595
- Locations
- 🇺🇸
University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath